Peptides 24 , 569578 (2003)
Am I currently taking medications that may interact with GLP-1 agonists - insulin, other diabetes medications, or medications affecting gastric motility
If a medication helps a person lose weight and they stop the medication, the basic biology regulating weight has not changed, and weight will be regained, Bessesen says
Impact This study provides age- and sex-specific reference values for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon in children and adolescents
Ideal candidates include those with BMI 30 (or 27 with comorbidities), stable cardiovascular history, normal kidney function, and no personal or family history of medullary thyroid cancer
GLP-1 Series Part 3: Mounjaro driving largest declines in insulin usage Contact sales for details